Shilpa Medicare
Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
DitchCarbon Score
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shilpa Medicare's score of 31 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shilpa Medicare's reported carbon emissions
In 2023, Shilpa Medicare reported total carbon emissions of approximately 36,903,10 kg CO2e across all scopes. This includes about 3,690,310 kg CO2e from Scope 1, which covers direct emissions from owned or controlled sources, and approximately 20,389,900 kg CO2e from Scope 2, representing indirect emissions from the generation of purchased electricity. Additionally, Scope 3 emissions, which account for other indirect emissions in the value chain, were about 710,410 kg CO2e. Comparatively, in 2022, the company recorded total emissions of around 15,232,280 kg CO2e, with Scope 1 emissions at approximately 1,523,280 kg CO2e, Scope 2 emissions at about 14,691,660 kg CO2e, and Scope 3 emissions at around 877,770 kg CO2e. This indicates a significant increase in emissions from 2022 to 2023. Shilpa Medicare has set ambitious climate commitments, aiming to be 100% powered by renewable energy sources by 2030 and achieving net-zero carbon emissions by 2050. These long-term goals reflect the company's dedication to leading the energy transition and reducing its overall carbon footprint across all scopes.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 1,523,280 | 0,000,000 |
| Scope 2 | 14,691,660 | 00,000,000 |
| Scope 3 | 877,770 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shilpa Medicare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
